πŸ‡ΊπŸ‡Έ FDA
Patent

US 8273786

3-phenoxymethylpyrrolidine compounds

granted A61KA61K31/40A61K31/4025

Quick answer

US patent 8273786 (3-phenoxymethylpyrrolidine compounds) held by Theravance, Inc. expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/40, A61K31/4025, A61P, A61P13/00